专题:Animal testing and alternatives

This cluster of papers focuses on improving the reporting and conduct of animal research studies, with an emphasis on the use of ARRIVE guidelines, cytotoxicity assays, ethical considerations, systematic reviews, in vitro testing methods, and addressing publication bias. It also discusses the challenges in translating findings from animal studies to human applications and the determination of sample sizes for preclinical studies.
最新文献
Beyond single metrics: Multi-parameter home-cage monitoring improves welfare assessment

article Full Text OpenAlex

GrimACE: automated, multimodal cage-side assessment of pain and well-being in mice

article Full Text OpenAlex

Justifying and reporting the use of severe stress in experiments that use animals

article Full Text OpenAlex

Variability and uncertainty of data from genotoxicity test guidelines: what we know and why it matters

article Full Text OpenAlex

Two Problems for the Political Inclusion of Animals

article Full Text OpenAlex

Effect of slaughter weight on the bromatological composition and energy value of rats (Rattus norvegicus) and mice (Mus musculus)

article Full Text OpenAlex

Beyond ‘Basic’ AI-Animal Alignment

article Full Text OpenAlex

Managing change while phasing out animal testing in chemical safety assessments – a collection of stakeholder experiences and expectations

article Full Text OpenAlex

Reaching the right: Engaging conservatives in animal welfare

article Full Text OpenAlex

Aspects éthiques et cadres juridiques de la recherche en neurosciences comportementales chez les primates non-humains

article Full Text OpenAlex

近5年高被引文献
Planning experiments: Updated guidance on experimental design and analysis and their reporting III

editorial Full Text OpenAlex 499 FWCI90.5138

Role of animal models in biomedical research: a review

review Full Text OpenAlex 410 FWCI85.0891

The BlueScreen HC assay to predict the genotoxic potential of fragrance materials

article Full Text OpenAlex 371 FWCI78.1846

FDA no longer has to require animal testing for new drugs

article Full Text OpenAlex 351 FWCI97.0338

BCPT 2023 policy for experimental and clinical studies

article Full Text OpenAlex 307 FWCI89.6196

New approach methodologies in human regulatory toxicology – Not if, but how and when!

review Full Text OpenAlex 286 FWCI88.5346

FDA Modernization Act 2.0 allows for alternatives to animal testing

article Full Text OpenAlex 280 FWCI49.8403

FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches

article Full Text OpenAlex 236 FWCI41.961

Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health

review Full Text OpenAlex 215 FWCI47.2717

A framework for establishing scientific confidence in new approach methodologies

review Full Text OpenAlex 214 FWCI21.4017